Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 4, Number 2—June 1998

Dispatch

Emergence of the M Phenotype of Erythromycin-Resistant Pneumococci in South Africa

Carol A. Widdowson and Keith P. Klugman
Author affiliations: South African Institute for Medical Research, Johannesburg, South Africa

Main Article

Table 2

Serotype distribution among erythromycin-resistant pneumococci

Serotype/ group No. (%) of
MLSa isolates No. (%) of
M isolates Total no.
(%) of isolates
14 96 (39.8) 9 (31.0) 105 (38.9)
6 71 (29.5) 3 (10.3) 74 (27.4)
19 36 (14.9) 3 (10.3) 39 (14.4)
23 26 (10.8) 10 (34.5) 36 (13.3)
1 7 (2.9) 1 (3.5) 8 (3.0)
Other 5 (2.1) 3 (10.3) 8 (3.0)
Total 241 29 270

aMLS, macrolides-lincosamides-streptogramin B.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO